News room

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

Press releases

Regulatory

May 31, 2022

Change in the number of shares and votes in Egetis Therapeutics

Read more

Regulatory

December 30, 2020

Change in the number of shares and votes in Egetis Therapeutics

Read more

Regulatory

November 30, 2020

Change in the number of shares and votes in PledPharma

Read more

Calendar and upcoming reports

August 19, 2022
Half-year report January - June

August 24, 2022
Erik Penser Bank Bolagsdag

Show more events

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com

Cookies
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept all”, you consent to the use of ALL the cookies. However, you may visit "Settings" to provide a controlled consent. Read our cookie policy
Settings Accept all
Cookies
Choose what kind of cookies to accept. Your choice will be saved for one year. Read our cookie policy
Save Accept all